Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor

Advances in Immunology

Volumn 75, Issue , 2000, Pages 283-316

  Hsueh, Robert C ^a   Scheuermann, Richard H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN MU CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN KINASE P60; PROTEIN TYROSINE KINASE;

APOPTOSIS; B LYMPHOCYTE DIFFERENTIATION; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CLONAL ANERGY; ENZYME ACTIVATION; GENE REARRANGEMENT; HUMAN; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033936847     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0065-2776(00)75007-3     Document Type: Review

References (140)

1. Ales-Martinez, J. E., Warner, G. L., and Scott, D. W. (1988). Immunoglobulins D and M mediate signals that are qualitatively different in B cells with an immature phenotype. Proc. Natl. Acad. Sci. USA 85, 6919-6923.
2. Alt, F. W., Enea, V., Bothwell, A. L., and Baltimore, D. (1980). Activity of multiple light chain genes in murine myeloma cells producing a single, functional light chain. Cell 21, 1-12.
3. Alt, F. W., Rosenberg, N., Enea, V., Siden, E., and Baltimore, D. (1982). Multiple immunoglobulin heavy-chain gene transcripts in Abelson murine leukemia virus-transformed lymphoid cell lines. Mol. Cell Biol. 2, 386-400.
4. Appleby, M. W., Kerner, J. D., Chien, S., Maliszewski, C. R., Bondada, S., Perlmutter, R. M., and Bondadaa, S. (1995). Involvement of p59fynT in interleukin-5 receptor signaling [published erratum appears in J. Exp. Med. 1995 Oct 1;182(4):1179]. J. Exp. Med. 182, 811-820.
5. Askew, D. S., Ashmun, R. A., Simmons, B. C., and Cleveland, J. L. (1991). Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6, 1915-1922.
6. Bauer, S. R., and Scheuermann, R. H. (1993). Expression of the VpreB/λ5/μ Pseudo-Ig complex correlates with downregulated RAG-1 expression and V(D)J type recombination: A mechanism for allelic exclusion at the IgH locus. Transgene 1, 33-45.
7. Benhamou, L. E., Cazenave, P. A., and Sarthou, P. (1990). Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 20, 1405-1407.
8. Benlagha, K., Guglielmi, P., Cooper, M. D., and Lassoued, K. (1999). Modifications of Ig alpha and Ig beta expression as a function of B lineage differentiation. J. Biol. Chem. 274, 19389-19396.
9. Bissonnette, R. P., Echeverri, F., Mahboubi, A., and Green, D. R. (1992). Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359, 552-554.
10. Brown, M. T., and Cooper, J. A. (1996). Regulation, substrates and functions of src. Biochim. Biophys. Acta 1287, 121-149.
11. Buerstedde, J. M., and Takeda, S. (1991). Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell 67, 179-188.
12. Burnet, F. M. (1959). "The Clonal Selection Theory of Acquired Immunity." Vanderbuilt Univ. Press, Nashville, TN.
13. Callard, K. E., Matthews, D. J., and Hibbert, L. (1996). IL-4 and IL-13 receptors: Are they one and the same? Immunol. Today 17, 108-110.
14. Cambier, J. C., Kettman, J. R., Vitetta, E. S., and Uhr, J. W. (1976). Differential susceptibility of neonatal and adult murine spleen cells to in vitro induction of B-cell tolerance. J. Exp. Med. 144, 293-297.
15. Cambier, J. C., Vitetta, E. S., Kettman, J. R., Wetzel, G. M., and Uhr, J. W. (1977). B-cell tolerance. III. Effect of papain-mediated cleavage of cell surface IgD on tolerance susceptibility of murine B cells. J. Exp. Med. 146, 107-117.
16. Campbell, K. S., Hager, E. J., Friedrich, R. J., and Cambier, J. C. (1991). IgM antigen receptor complex contains phosphoprotein products of B29 and mb-1 genes. Proc. Natl. Acad. Sci. USA 88, 3982-3986.
17. Chan, V. W., Meng, F., Soriano, P., DeFranco, A. L., and Lowell, C. A. (1997). Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and downregulation. Immunity 7, 69-81.
18. Chang, T. L., Capraro, G., Kleinman, R. E., and Abbas, A. K. (1991). Anergy in immature B lymphocytes. Differential responses to receptor-mediated stimulation and T helper cells. J. Immunol. 147, 750-756.
19. Cheng, A. M., Rowley, B., Pao, W., Hayday, A., Bolen, J. B., and Pawson, T. (1995). Syk tyrosine kinase required for mouse viability and B-cell development. Nature 378, 303-306.
20. Chu, D. H., Morita, C. T., and Weiss, A. (1998). The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol. Rev. 165, 167-180.
21. Cohen, G. B., Ren, R., and Baltimore, D. (1995). Modular binding domains in signal transduction proteins. Cell 80, 237-248.
22. Coleclough, C., Perry, R. P., Karjalainen, K., and Weigert, M. (1981). Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature 290, 372-378.
23. Cornall, R. J., Cyster, J. G., Hibbs, M. L., Dunn, A. R., Otipoby, K. L., Clark, E. A., and Goodnow, C. C. (1998). Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8, 497-508.
24. Courtneidge, S. A., Levinson, A. D., and Bishop, J. M. (1980). The protein encoded by the transforming gene of avian sarcoma virus (pp60src) and a homologous protein in normal cells (pp60proto-src) are associated with the plasma membrane. Proc. Natl. Acad. Sci. USA 77, 3783-3787.
25. Cross, F. K., Garber, E. A., Pellman, D., and Hanafusa, H. (1984). A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation. Mol. Cell. Biol. 4, 1834-1842.
26. de Weers, M., Mensink, R. G., Kraakman, M. E., Schuurman, R. K., and Hendriks, R. W. (1994). Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: Identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. Hum. Mol. Genet. 3, 161-166.
27. Deckert, M., Tartare-Deckert, S., Couture, C., Mustelin, T., and Altman, A. (1996). Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 5, 591-604.
28. Desiderio, S. (1997). Role of Btk in B cell development and signaling. Curr. Opin. Immunol. 9, 534-540.
29. Erikson, J., Radic, M. Z., Camper, S. A., Hardy, R. R., Carmack, C., and Weigert, M. (1991). Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349, 331-334.
30. Fanidi, A., Harrington, E. A., and Evan, G. I. (1992). Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359, 554-556.
31. Felder, S., Zhou, M., Hu, P., Urena, J., Ullrich, A., Chaudhuri, M., White, M., Shoelson, S. E., and Schlessinger, J. (1993). SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange. Mol. Cell. Biol. 13, 1449-1455.
32. Feng, S., Chen, J. K., Yu, H., Simon, J. A., and Schreiber, S. L. (1994). Two binding orientations for peptides to the Src SH3 domain: Development of a general model for SH3-ligand interactions. Science 266, 1241-1247.
33. Flaswinkel, H., and Reth, M. (1994). Dual role of the tyrosine activation motif of the Ig-alpha protein during signal transduction via the B cell antigen receptor. EMBO J. 13, 83-89.
34. Gay, D., Saunders, T., Camper, S., and Weigert, M. (1993). Receptor editing: An approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177, 999-1008.
35. Go, N. F., Castle, B. E., Barrett, R., Kastelein, R., Dang, W., Mosmann, T. R., Moore, K. W., and Howard, M. (1990). Interleukin 10, a novel B cell stimulatory factor: Unresponsiveness of X chromosome-finked immunodeficiency B cells. J. Exp. Med. 172, 1625-1631.
36. Gong, S., Sanchez, M., and Nussenzweig, M. C. (1996). Counterselection against D mu is mediated through immunoglobulin (Ig)alpha-Igbeta. J. Exp. Med. 184, 2079-2084.
37. Goodman, S.A., Vitetta, E. S., Melcher, U., and Uhr, J. W. (1975). Cell surface immunoglobulin. XIII. Distribution of IgM and IgD-like molecules on small and large cells of mouse spleen. J. Immunol. 114, 1646-1648.
38. Goodnow, C. C., Brink, R., and Adams, E. (1991). Breakdown of self-tolerance in anergic B lymphocytes. Nature 352, 532-536.
39. Goodnow, C. C., Crosbie, J., Adelstein, S., Lavoie, T. B., Smith-Gill, S. J., Brink, R. A., Pritchard-Briscoe, H., Wotherspoon, J. S., Loblay, R. H., Raphael, K. et al. (1988). Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676-682.
40. Grawunder, U., Leu, T. M., Schatz, D. G., Werner, A., Rolink, A. G., Melchers, F., and Winkler, T. H. (1995). Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 3, 601-608.
41. Grewal, I. S., and Flavell, R. A. (1998). CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16, 111-135.
42. Hammill, A. K., Uhr, J. W., and Scheuermann, R. H. (1999). Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp. Cell Res. 251, 16-21.
43. Hartley, S. B., Crosbie, J., Brink, R., Kantor, A. B., Basten, A., and Goodnow, C. C. (1991). Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353, 765-769.
44. Hasbold, J., and Klaus, G. G. (1990). Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur. J. Immunol. 20, 1685-1690.
45. Hata, A., Sabe, H., Kurosaki, T., Takata, M., and Hanafusa, H. (1994). Functional analysis of Csk in signal transduction through the B-cell antigen receptor. Mol. Cell. Biol. 14, 7306-7313.
46. Havran, W. L., DiGiusto, D. L., and Cambier, J. C. (1984). mIgM:mIgD ratios on B cells: Mean mIgD expression exceeds mIgM by 10-fold on most splenic B cells. J. Immunol. 132, 1712-1716.
47. Healy, J. I., and Goodnow, C. C. (1998). Positive versus negative signaling by lymphocyte antigen receptors. Anu. Rev. Immunol. 16, 645-670.
48. Hertz, M., and Nemazee, D. (1997). BCR ligation induces receptor editing in IgM+IgD-bone marrow B cells in vitro. Immunity 6, 429-436.
49. Hibbs, M. L., Tarlinton, D. M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., Stacker, S. A., and Dunn, A. R. (1995). Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83, 301-311.
50. Hollowood, K., and Goodlad, J. R. (1998). Germinal centre cell kinetics. J. Pathol. 185, 229-233.
51. Hombach, J., Leclercq, L., Radbruch, A., Rajewsky, K., and Reth, M. (1988). A novel 34-kd protein co-isolated with the IgM molecule in surface IgM-expressing cells. EMBO J. 7, 3451-3456.
52. Hombach, J., Tsubata, T., Leclercq, L., Stappert, H., and Reth, M. (1990). Molecular components of the B-cell antigen receptor complex of the IgM class. Nature 343, 760-762.
53. Hsueh, K. C., Hammill, A. K., Marches, K., Uhr, J. W., and Scheuermann, R. H. (1999). Antigen receptor signaling induces differential tyrosine kinase activation and population stability in B-cell lymphoma. Curr. Top. Micro. Immunol. 246, 299-305.
54. Kerner, J. D., Appleby, M. W., Mohr, K. N., Chien, S., Rawlings, D. J., Maliszewski, C. R., Witte, O. N., and Perlmutter, R. M. (1995). Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3, 301-312.
55. Khan, W. N., Alt, F. W., Gerstein, K. M., Malynn, B. A., Larsson, I., Rathbun, G., Davidson, L., Müller, S., Kantor, A. B., Herzenberg, L. A. et al. (1995). Defective B cell development and function in Btk-deficient mice. Immunity 3, 283-299.
56. Kitamura, D., Kudo, A., Schaal, S., Muller, W., Melchers, F., and Rajewsky, K. (1992). A critical role of lambda 5 protein in B cell development. Cell 69, 823-831.
57. Kitamura, D., Roes, J., Kuhn, R., and Rajewsky, K. (1991). A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423-426.
58. Klaus, G. G., Holman, M., and Hasbold, J. (1994). Properties of mouse CD40: The role of homotypic adhesion in the activation of B cells via CD40. Eur. J. Immunol. 24, 2714-2719.
59. Klinman, N. K. (1996). The "clonal selection hypothesis" and current concepts of B cell tolerance. Immunity 5, 189-195.
60. Kmiecik, T. E., and Shalloway, D. (1987). Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49, 65-73.
61. Kurosaki, T. (1999). Genetic analysis of B cell antigen receptor signaling. Ann. Rev. Immunol. 17, 555-592.
62. Kurosaki, T., Takata, M., Yamanashi, Y., Inazu, T., Taniguchi, T., Yamamoto, T., and Yamamura, H. (1994). Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. J. Exp. Med. 179, 1725-1729.
63. Lam, K. P., Kuhn, R., and Rajewsky, K. (1997). In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073-1083.
64. Lanier, L. L., and Warner, N. L. (1981). Cell cycle related heterogeneity of Ia antigen expression on a murine B lymphoma cell line:analysis by flow cytometry. J. Immunol. 126, 626-631.
65. Law, C. L., Chandran, K. A., Sidorenko, S. P., and Clark, E. A. (1996). Phospholipase C-gammal interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol. Cell. Biol. 16, 1305-1315.
66. Law, C. L., Sidorenko, S. P., Chandran, K. A., Draves, K. E., Chan, A. C., Weiss, A., Edelhoff, S., Disteche, C. M., and Clark, E. A. (1994). Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex. J. Biol. Chem. 269, 12310-12319.
67. Lim, W. A., Richards, F. M., and Fox, R. O. (1994). Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains [published erratum appears in Nature 1995 Mar 2;374(6517):94]. Nature 372, 375-379.
68. Lowenthal, J. W., Zubler, K. H., Nabholz, M., and MacDonald, H. K. (1985). Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. Nature 315, 669-672.
69. Ma, A., Fisher, P., Dildrop, K., Oltz, E., Rathbun, G., Achacoso, P., Stall, A., and Alt, F. W. (1992). Surface IgM mediated regulation of RAG gene expression in E mu-N-myc B cell lines. EMBO J. 11, 2727-2734.
70. Malek, S. N., Dordai, D. L, Reim, J., Dintzis, H., and Desiderio, S. (1998). Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. Proc. Natl. Acad. Sci. USA 95, 7351-7356.
71. Marches, R., Hsueh, R., and Uhr, J. W. (1999). Cancer dormancy and cell signaling: Induction of p21(waf1) initiated by membrane IgM engagement increases survival of B lymphoma cells. Proc. Natl. Acad. Sci. USA 96, 8711-8715.
72. Marches, K., Racila, E., Tucker, T. F., Picker, L., Mongini, P., Hsueh, R., Vitetta, E. S., Scheuermann, R. H., and Uhr, J. W. (1995). Tumour dormancy and cell signalling - III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells. Ther. Immunol. 2, 125-136.
73. Metcalf, E. S., and Klinman, N. R. (1977). In vitro tolerance induction of bone marrow cells: A marker for B cell maturation. J. Immunol. 118, 2111-2116.
74. Metcalf, E. S., and Klinman, N. R. (1976). In vitro tolerance induction of neonatal murine B cells. J. Exp. Med. 143, 1327-1340.
75. Monroe, J. G. (1996). Tolerance sensitivity of immature-stage B cells: Can developmentally regulated B cell antigen receptor (BCR) signal transduction play a role? J. Immunol. 156, 2657-2660.
76. Mustelin, T. (1994). "Src Family Tyrosine Kinases in Leukocytes" (C. Kerkaporta, ed.). R. G. Landes Company, Austin, TX.
77. Nemazee, D. A., and Burki, K. (1989). Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337, 562-566.
78. Neuberger, M. S. (1997). Antigen receptor signaling gives lymphocytes a long life. Cell 90, 971-973.
79. Nishizumi, H., Taniuchi, I., Yamanashi, Y., Kitamura, D., Ilic, D., Mori, S., Watanabe, T., and Yamamoto, T. (1995). Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3, 549-560.
80. Nitschke, L., Kosco, M. H., Kohler, G., and Lamers, M. C. (1993). Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens. Proc. Natl. Acad. Sci. USA 90, 1887-1891.
81. Norvell, A., Mandik, L., and Monroe, J. G. (1995). Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. J. Immunol. 154, 4404-4413.
82. Okamoto, M., Murakami, M., Shimizu, A., Ozaki, S., Tsubata, T., Kumagai, S., and Honjo, T. (1992). A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 175, 71-79.
83. Panayotou, G., Gish, G., End, P., Truong, O., Gout, I., Dhand, K., Fry, M. J., Hiles, I., Pawson, T., and Waterfield, M. D. (1993). Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor beta-receptor sequences: Analysis of kinetic parameters by a novel biosensor-based approach. Mol. Cell. Biol. 13, 3567-3576.
84. Pao, L. I., and Cambier, J. C. (1997). Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45- B cells. J. Immunol. 158, 2663-2669.
85. Pawson, T. (1995). Protein modules and signalling networks. Nature 373, 573-580.
86. Pennell, C. A., and Scott, D. W. (1986). Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells. Eur. J. Immunol. 16, 1577-1581.
87. Piwnica-Worms, H., Saunders, K. B., Roberts, T. M., Smith, A. E., and Cheng, S. H. (1987). Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell 49, 75-82.
88. Pleiman, C. M., Hertz, W. M., and Cambier, J. C. (1994). Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to the p85 subunit. Science 263, 1609-1612.
89. Radic, M. Z., Erikson, J., Litwin, S., and Weigert, M. (1993). B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177, 1165-1173.
90. Raff, M. C., Owen, J. J., Cooper, M. D., Lawton, A. R. d., Megson, M., and Gathings, W. E. (1975). Differences insusceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulin-induced immunoglobulin suppression in vitro. Possible implications for B-cell tolerance to self. J. Exp. Med. 142, 1052-1064.
91. Rawlings, D. J., Saffran, D. C., Tsukada, S., Largaespada, D. A., Grimaldi, J. C., Cohen, L., Mohr, R. N., Bazan, J. F., Howard, M., Copeland, N. G., et al. (1993). Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261, 358-361.
92. Rawlings, D. J., Scharenberg, A. M., Park, H., Wahl, M. I., Lin, S., Kato, R. M., Fluckiger, A. C., Witte, O. N., and Kinet, J. P. (1996). Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 271, 822-825.
93. Reth, M. (1989). Antigen receptor tail clue [letter]. Nature 338, 383-384.
94. Reth, M., and Wienands, J. (1997). Initiation and processing of signals from the B cell antigen receptor. Annu. Rev. Immunol, 15, 453-479.
95. Retter, M. W., and Nemazee, D. (1998). Receptor editing occurs frequently during normal B cell development. J. Exp. Med. 188, 1231-1238.
96. Rothstein, T. L., Wang, J. K., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S. T., and Marshak-Rothstein, A. (1995). Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374, 163-165.
97. Samelson, L. E., and Klausner, R. D. (1992). Tyrosine kinases and tyrosine-based activation motifs. Current research on activation via the T cell antigen receptor. J. Biol. Chem. 267, 24913-24916.
98. Sanchez, M., Misulovin, Z., Burkhardt, A. L., Mahajan, S., Costa, T., Franke, R., Bolen, J. B., and Nussenzweig, M. (1993). Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. J. Exp. Med. 178, 1049-1055.
99. Santos-Argumedo, L., Lund, F. E., Heath, A. W., Solvason, N., Wu, W. W., Grimaldi, J. C., Parkhouse, R. M., and Howard, M. (1995). CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction. Int. Immunol. 7, 163-170.
100. Sato, S., Katagiri, T., Takaki, S., Kikuchi, Y., Hitoshi, Y., Yonehara, S., Tsukada, S., Kitamura, D., Watanabe, T., Witte, O., et al. (1994). IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 Kinases. J. Exp. Med. 180, 2101-2111.
101. Scheuermann, R. H., Racila, E., Tucker, T., Yefenof, E., Street, N. E., Vitetta, E. S., Picker, L. J., and Uhr, J. W. (1994). Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells. Proc. Natl. Acad. Sci. USA 91, 4048-4052.
102. Scheuermann, R. H., and Uhr, J. W. (1995). Connections between signal transduction components and cellular responses initiated by antigen receptor on B lymphocytes. J. Exp. Med. 182, 903-906.
103. Scott, D. W., Layton, J. E., and Nossal, G. J. (1977). Role of IgD in the immune response and tolerance. I. Anti-delta pretreatment facilitates tolerance induction in adult B cells in vitro. J. Exp. Med. 146, 1473-1483.
104. Scott, D. W., Livnat, D., Pennell, C. A., and Keng, P. (1986). Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu. J. Exp. Med. 164, 156-164.
105. Sicheri, F., Moarefi, I., and Kuriyan, J. (1997). Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609.
106. Sideras, P., and Smith, C. I. (1995). Molecular and cellular aspects of X-linked agamma-globulinemia. Adv. Immunol. 59, 135-223.
107. Sillman, A. L., and Monroe, J. G. (1994). Surface IgM-stimulated proliferation, inositol phospholipid hydrolysis, Ca2+ flux, and tyrosine phosphorylation are not altered in B cells from p59fyn-1- mice. J. Leukoc. Biol. 56, 812-816.
108. Sleckman, B. P., Bassing, C. H., Bardon, C. G., Okada, A., Khor, B., Bories, J. C., Monroe, R., and Alt, F. W. (1998). Accessibility control of variable region gene assembly during T-cell development. Immunol. Rev. 165, 121-130.
109. Smith, C. I., Baskin, B., Humire-Greiff, P., Zhou, J. N., Olsson, P. G., Maniar, H. S., Kjellen, P., Lambris, J. D., Christensson, B., Hammarstrom, L., et al. (1994). Expression of Bruton's agammaglobulinemia tryosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J. Immunol. 152, 557-565.
110. Solvason, N., Wu, W. W., Kabra, N., Lund-Johansen, F., Roncarolo, M. G., Behrens, T. W., Grillot, D. A., Nunez, G., Lees, E., and Howard, M. (1998). Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J. Exp. Med. 187, 1081-1091.
111. Strasser, A. (1991). B cell tumors. In "Mechanisms of B Cell Neoplasia 1991" (F. Melchers and M. Potter, eds.), pp. 181-186. Hoffmann-La Roche, Basel, Switzerland.
112. Takata, M., Homma, Y., and Kurosaki, T. (1995). Requirement of phospholipase C-gamma 2 activation in surface immunoglobulin M-induced B cell apoptosis. J. Exp. Med. 182, 907-914.
113. Takata, M., Sabe, H., Hata, A., Inazu, T., Homma, Y., Nukada, T., Yamamura, H., and Kurosaki, T. (1994). Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J. 13, 1341-1349.
114. Tamir, I., and Cambier, J. C. (1998). Antigen receptor signaling: Integration of protein tyrosine kinase functions. Oncogene 17, 1353-1364.
115. Teale, J. M., and Klinman, N. R. (1984). Membrane and metabolic requirements for tolerance induction of neonatal B cells. J. Immunol. 133, 1811-1817.
116. Teale, J. M., and Klinman, N. R. (1980). Tolerance as an active process. Nature 288, 385-387.
117. Teh, Y. M., and Neuberger, M. S. (1997). The immunoglobulin (Ig) alpha and Ig-beta cytoplasmic domains are independently sufficient to signal B cell maturation and activation in transgenic mice. J. Exp. Med. 185, 1753-1758.
118. Thomas, J. D., Sideras, P., Smith, C. I., Vorechovsky, I., Chapman, V., and Paul, W. E. (1993). Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261, 355-358.
119. Tiegs, S. L., Russell, D. M., and Nemazee, D. (1993). Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177, 1009-1020.
120. Tisch, R., Roifman, C. M., and Hozumi, N. (1988). Functional differences between immunoglobulins M and D expressed on the surface of an immature B-cell line. Proc. Natl. Acad. Sci. USA 85, 6914-6918.
121. Torres, R. M., Flaswinkel, H., Reth, M., and Rajewsky, K. (1996). Aberrant B cell development and immune response in mice with a compromised BCR complex. Science 272, 1804-1808.
122. Tseng, J., Eisfelder, B. J., and Clark, M. R. (1997). B-cell antigen receptor-induced apoptosis requires both Ig alpha and Ig beta. Blood 89, 1513-1520.
123. Tsukada, S., Saffran, D. C., Rawlings, D. J., Parolini, O., Allen, R. C., Elisak, I., Sparkes, R. S., Kubagawa, H., Mohandas, T., Quan, S., et al. (1993). Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72, 279-290.
124. Turner, M., Mee, P. J., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P., Furlong, M. T., Geahlen, R. L., and Tybulewicz, V. L. (1995). Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378, 298-302.
125. Tybulewicz, V. L. (1998). Analysis of antigen receptor signalling using mouse gene targeting. Curr. Opin. Cell. Biol. 10, 195-204.
126. Uckun, F. M., Waddick, K. G., Mahajan, S., Jun, X., Takata, M., Bolen, J., and Kurosaki, T. (1996). BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 273, 1096-1100.
127. Vetrie, D., Vorechovsky, I., Sideras, P., Holland, J., Davies, A., Flinter, F., Hammarstrom, L., Kinnon, C., Levinsky, R., Bobrow, M., et al. (1993). The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases [published erratum appears in Nature 1993 Jul 22;364(6435):362]. Nature 361, 226-233.
128. Vitetta, E. S., Cambier, J. C., Ligler, F. S., Kettman, J. R., and Uhr, J. W. (1977). B-cell tolerance. IV. Differential role of surface IgM and IgD in determining tolerance susceptibility of murine B cells. J. Exp. Med. 146, 1804-1808.
129. Vitetta, E. S., Melcher, U., McWilliams, M., Lamm, M. E., Phillips-Quagliata, J. M., and Uhr, J. W. (1975). Cell surface immunoglobulin. XI. The appearance of an IgD-like molecule on murine lymphoid cells during ontogeny. J. Exp. Med. 141, 206-215.
130. Wang, J., Koizumi, T., and Watanabe, T. (1996). Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice. J. Exp. Med. 184, 831-838.
131. Webb, C. F., Nakai, C., and Tucker, P. W. (1989). Immunoglobulin receptor signaling depends on the carboxyl terminus but not the heavy-chain class. Proc. Natl. Acad. Sci. USA 86, 1977-1981.
132. Wechsler, R. J., and Monroe, J. G. (1995). Src-family tyrosine kinase p55fgr is expressed in murine splenic B cells and is activated in response to antigen receptor cross-linking. J. Immunol. 154, 3234-3244.
133. Weiss, A. (1993). T cell antigen receptor signal transduction: A tale of tails and cytoplasmic protein-tyroisine kinases. Cell 73, 209-212.
134. Wu, M., Bellas, R. E., Shen, J., and Sonenshein, G. E. (1998). Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in receptor-mediated apoptosis of WEHI 231 B lymphoma cells. J. Exp. Med. 187, 1671-1679.
135. Xu, W., Harrison, S. C., and Eck, M. J. (1997). Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602.
136. Yamanashi, Y., Okada, M., Semba, T., Yamori, T., Umemori, H., Tsunasawa, S., Toyoshima, K., Kitamura, D., Watanabe, T., and Yamamoto, T. (1993). Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. Proc. Natl. Acad. Sci. USA 90, 3631-3635.
137. Yanagi, S., Sugawara, H., Kurosaki, M., Sabe, H., Yamamura, H., and Kurosaki, T. (1996). CD45 modulates phosphorylation of both autophosphorylation and negative regulatory tyrosines of Lyn in B cells. J. Biol Chem. 271, 30487-30492.
138. Yasue, T., Nishizumi, H., Aizawa, S., Yamamoto, T., Miyake, K., Mizoguchi, C., Uehara, S., Kikuchi, Y., and Takatsu, K. (1997). A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5. Proc. Natl. Acad. Sci. USA 94, 10307-10312.
139. Yefenof, E., Picker, L. J., Scheuermann, K. H., Tucker, T. F., Vitetta, E. S., and Uhr, J. W. (1993). Cancer dormancy: Isolation and characterization of dormant lymphoma cells. Proc. Natl. Acad. Sci. USA 90, 1829-1833.
140. Yellen, A. J., Glenn, W., Sukhatme, V. P., Cao, X. M., and Monroe, J. G. (1991). Signaling through surface IgM in tolerance-susceptible immature murine B lymphocytes. Developmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice. J. Immunol. 146, 1446-1454.